Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A green evaluation marketed as an different to a mammogram for breast cancer detection is not an serviceable screening TOOL, US health officials say. With the nipple aspirate test, a chest pump collects runny from a woman's nipple. The fluid is then examined for oddball and potentially cancerous cells viagra. The test is advertised as easier, more agreeable and less painful than mammograms.

However, there is no proof to support claims that the study can detect breast cancer, said Dr David Lerner, a medical fuzz at the US Food and Drug Administration and a tit imaging specialist. "FDA's concern is that the nipple aspirate evaluate is being touted as a standalone tool to screen for and identify breast cancer as an alternative to mammography," Lerner said in an power news release.

So "Our fear is that women will forgo a mammogram and have this check-up instead". Skipping a mammogram could put a woman's healthfulness and life at risk if breast cancer goes undetected, Lerner warned. He said there is no meticulous evidence that the nipple aspirate test, when occupied on its own, is an effective screening tool for core cancer or any other medical condition.

The test is still being studied to determine if it might be usable in combination with other methods to screen for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of boob cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate check - called the ForeCYTE Breast Health Test - off the sell after being warned by the FDA that its claims about the try were unsubstantiated. The house claimed the proof was "literally a Pap blot for breast cancer". Pap smears are a standard assess for cervical cancer.

And Women who have had a nipple aspirate test as a attitude of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should babble to their doctor about whether additional tests are needed, the FDA said. One in eight US women will grow heart cancer in her lifetime anti diabetes slogan. The disease is the substitute leading cancer killer of women in the country.